CALC logo

CALC
CalciMedica Inc

3,536
Mkt Cap
$9.73M
Volume
170,302.00
52W High
$7.20
52W Low
$0.4606
PE Ratio
-0.31
CALC Fundamentals
Price
$0.6178
Prev Close
$0.651
Open
$0.641
50D MA
$0.6502
Beta
0.43
Avg. Volume
452,712.17
EPS (Annual)
-$1.97
P/B
-1.44
Rev/Employee
$0.00
$95.61
Loading...
Loading...
News
all
press releases
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates CalciMedica Reports 2025 Financial Results and Provides Clinical Updates PR Newswire LA JOLLA, Calif., March 3, 2026 Internal...
PR Newswire·1mo ago
News Placeholder
More News
News Placeholder
How Is The Market Feeling About CalciMedica Inc?
read more...
Benzinga·2mo ago
News Placeholder
CALC Stock Slumped 76% On Wednesday — Here’s Why
CalciMedica said that it has decided to discontinue the trial evaluating its lead product candidate Auxora in patients with Stage 2 or Stage 3 acute kidney injury following a committee recommendation.
Stocktwits·2mo ago
News Placeholder
CalciMedica (NASDAQ:CALC) Upgraded to Sell at Wall Street Zen
Wall Street Zen upgraded CalciMedica to a "sell" rating in a report on Saturday...
MarketBeat·3mo ago
News Placeholder
CalciMedica (NASDAQ:CALC) Trading Down 2.1% - Time to Sell?
CalciMedica (NASDAQ:CALC) Stock Price Down 2.1% - Time to Sell...
MarketBeat·3mo ago
News Placeholder
Stonepine Capital Management LLC Has $136,000 Stock Position in CalciMedica Inc. $CALC
Stonepine Capital Management LLC lowered its stake in shares of CalciMedica Inc. (NASDAQ:CALC - Free Report) by 76.9% during the second quarter, according to the company in its most recent filing...
MarketBeat·4mo ago
News Placeholder
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates...
PR Newswire·5mo ago
News Placeholder
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension CalciMedica Announces Publication in...
PR Newswire·5mo ago
News Placeholder
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora CalciMedica and Telperian Announce Collaboration to...
PR Newswire·6mo ago
<
...
1
>

Latest CALC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.